Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1744-1755

  Mahfoud, Radhia ^a   Manis, Adam ^a,b   Lingwood, Clifford A ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cholesterol; DRM; HIVgp120; Langmuir trough; Lipid raft; Sucrose gradient; Verotoxin 1; Verotoxin 2

Indexed keywords

CELL RECEPTOR; CHOLESTEROL; GLOBOTRIAOSYLCERAMIDE RECEPTOR; GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE RESISTANCE; CELL SURFACE; CONTROLLED STUDY; HUMAN; LIPID COMPOSITION; LIPID MONOLAYER; LIPID VESICLE; MEMBRANE BINDING; MEMBRANE COMPONENT; MEMBRANE MODEL; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION;

CELL MEMBRANE; CHOLESTEROL; DETERGENTS; FATTY ACIDS; HIV ENVELOPE PROTEIN GP120; HUMANS; LIGANDS; MEMBRANE FLUIDITY; PRESSURE; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES;

EID: 70350389557     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800385-JLR200     Document Type: Article

References (65)

1. Lingwood, C. A. 1993. Verotoxins and their glycolipid receptors. In Sphingolipids. Part A: Functions and Breakdown Products. Advances in Lipid Research. R. Bell, Y. A. Hannun, and A. Merrill Jr., editors. Academic Press, San Diego. 189-212.
2. Okuda, T., N. Tokuda, S. Numata, M. Ito, M. Ohta, K. Kawamura, J. Wiels, T. Urano, O. Tajima, and K. Furukawa. 2006. Targeted disruption of Gb3/ CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J. Biol. Chem. 281: 10230-10235.
3. Falguieres, T., F. Mallard, C. Baron, D. Hanau, C. Lingwood, B. Goud, J. Salamero, and L. Johannes. 2001. Targeting of Shiga toxin b-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell. 12: 2453-2468.
4. Smith, D. C., D. J. Sillence, T. Falguieres, R. M. Jarvis, L. Johannes, J. M. Lord, F. M. Platt, and L. M. Roberts. 2006. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17: 1375-1387.
5. Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37: 497-503.
6. Miceli, S., M. A. Jure, O. A. de Saab, M. C. de Castillo, S. Rojas, A. P. de Holgado, and O. M. de Nader. 1999. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina. Jpn. J. Infect. Dis. 52: 33-37.
7. Tam, P., R. Mahfoud, A. Nutikka, A. Khine, B. Binnington, P. Paroutis, and C. Lingwood. 2008. Differential intracellular trafficking and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J. Cell. Physiol. 216: 750-763.
8. Lingwood, C. A. 1996. Aglycone modulation of glycolipid receptor function. Glycoconj. J. 13: 495-503.
9. Kiarash, A., B. Boyd, and C. A. Lingwood. 1994. Glycosphingolipid receptor function is modified by fatty acid content: Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269: 11138-11146.
10. Pellizzari, A., H. Pang, and C. A. Lingwood. 1992. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry. 31: 1363-1370.
11. Binnington, B., D. Lingwood, A. Nutikka, and C. Lingwood. 2002. Effect of globotriaosyl ceramide fatty acid hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem. Res. 27: 807-813.
12. Romer, W., L. Berland, V. Chambon, K. Gaus, B. Windschiegl, D. Tenza, M. R. Aly, V. Fraisier, J. C. Florent, D. Perrais, et al. 2007. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 450: 670-675.
13. Arab, S., and C. A. Lingwood. 1996. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a surface bilayer film and liposomes. Glycoconj. J. 13: 159-166.
14. Chark, D., A. Nutikka, N. Trusevych, J. Kuzmina, and C. Lingwood. 2004. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and monoclonal antibody: role in human renal glomerular binding. Eur. J. Biochem. 271: 405-417.
15. Arab, S., and C. Lingwood. 1998. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to Verotoxin: sodium butyrate or selection of drug resistance may induce nuclear toxin targeting via globotriaosyl ceramide fatty acid isoform traffic. J. Cell. Physiol. 177: 646-660.
16. Wang, T. Y., and J. R. Silvius. 2000. Different sphingolipids show differential partitioning into sphingolipid/cholesterol-rich domains in lipid bilayers. Biophys. J. 79: 1478-1489.
17. Bhat, S., R. V. Mettus, E. P. Reddy, K. E. Ugen, V. Srikanthan, W. V. Williams, and D. B. Weiner. 1993. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res. Hum. Retroviruses. 9: 175-181.
18. Hammache, D., G. Piéroni, N. Yahi, O. Delézay, N. Koch, H. Lafont, C. Tamalet, and J. Fantini. 1998. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273: 7967-7971.
19. Hammache, D., N. Yahi, M. Maresca, G. Pieroni, and J. Fantini. 1999. Human erythrocyte glycosphingolipids as alternative co-factors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 73: 5244-5248.
20. Lund, N., D. Branch, M. Mylvaganam, D. Chark, X. Ma, D. Sakac, B. Binnington, J. Fantini, A. Puri, R. Blumenthal, et al. 2006. A novel soluble mimic of the glycolipid globotriaosylceramide inhibits HIV infection. AIDS. 20: 333-343.
21. Lund, N., M. L. Olsson, S. Ramkumar, D. Sakac, Y. Yahalom, C. Levene, A. Hellberg, X. Ma, B. Binnington, D. Jung et al. Protection against HIV-1 infection by the human P k blood group antigen. Epub ahead of print. January 12, 2009; DOI 10.1182/blood-2008-03-143396.
22. Ramkumar, S., D. Sakac, B. Binnington, D. R. Branch, and C. A. Lingwood. 2009. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. Glycobiology. 19: 76-82.
23. Nutikka, A., and C. Lingwood. 2004. Generation of receptor active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro: a new assay to define factors affecting glycosphingolipid receptor activity. Glycoconj. J. 20: 33-38.
24. 3 interaction. J. Lipid Res. 43: 1670-1679.
25. Nutikka, A., B. Binnington-Boyd, and C. A. Lingwood. 2003. Methods for the purification of Shiga toxin 1. In Methods in Molecular Medicine. D. Philpot and F. Ebel, editors. Humana Press, Totowa, NY. 187-195.
26. Head, S. C., M. A. Karmali, and C. A. Lingwood. 1991. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits: evidence for B subunit modulation of A subunit function. J. Biol. Chem. 266: 3617-3621.
27. Mahfoud, R., M. Maresca, M. Santelli, A. Pfohl-Leszkowicz, A. Puigserver, and J. Fantini. 2002. pH-dependent interaction of fumonisin B1 with cholesterol: physicochemical and molecular modeling studies at the air-water interface. J. Agric. Food Chem. 50: 327-331.
28. Rietveld, A., and K. Simons. 1998. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta. 1376: 467-479.
29. Brown, D. A., and E. London. 1998. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164: 103-114.
30. Pitman, M. C., F. Suits, A. D. Mackerell, Jr., and S. E. Feller. 2004. Molecular-level organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol. Biochemistry. 43: 15318-15328.
31. Ali, S., H. Brockman, and R. Brown. 1991. Structural determinants of miscibility in surface films of galactosyl ceramide and phosphatidyl choline:effect of unsaturation in the galactosyl ceramide acyl chain. Biochemistry. 30: 11198-11205.
32. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572.
33. Ait Slimane, T., and D. Hoekstra. 2002. Sphingolipid trafficking and protein sorting in epithelial cells. FEBS Lett. 529: 54-59.
34. Maggio, B. 1994. The surface behavior of glycosphingolipids in biomembranes: a new frontier of molecular ecology. Prog. Biophys. Mol. Biol. 62: 55-117.
35. Brown, D. A. 2006. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda). 21: 430-439.
36. Kasahara, K., and Y. Sanai. 2000. Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconj. J. 17: 153-162.
37. Lingwood, D., and K. Simons. 2007. Detergent resistance as a tool in membrane research. Nature Protocols. 2: 2159-2165.
38. Hirai, M., M. Koizumi, H. Hirai, T. Hayakawa, K. Yuyama, N. Suzuki, and K. Kasahara. 2005. Structures and dynamics of glycosphingoat lipid-containing lipid mixtures as raft models of plasma membrane. J. Phys. Condens. Matter. 17: S2965-S2977.
39. McIntosh, T. J. 1978. The effect of cholesterol on the structure of phosphatidylcholine bilayers. Biochim. Biophys. Acta. 513: 43-58.
40. McMullen, T. P., R. N. Lewis, and R. N. McElhaney. 1993. Differential scanning calorimetric study of the effect of cholesterol on the thermotropic phase behavior of a homologous series of linear saturated phosphatidylcholines. Biochemistry. 32: 516-522.
41. Wassall, S. R., M. R. Brzustowicz, S. R. Shaikh, V. Cherezov, M. Caffrey, and W. Stillwell. 2004. Order from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation. Chem. Phys. Lipids. 132: 79-88.
42. Boyd, B., Z. Zhiuyan, G. Magnusson, and C. A. Lingwood. 1994. Lipid modulation of glycolipid receptor function: presentation of galactose α1-4 galactose disaccharide for Verotoxin binding in natural and synthetic glycolipids. Eur. J. Biochem. 223: 873-878.
43. Hilaire, N., A. Negre-Salvayre, and R. Salvayre. 1994. Cellular uptake and catabolism of high-density-lipoprotein triacylglycerols in human cultured fibroblasts: degradation block in neutral lipid storage disease. Biochem. J. 297: 467-473.
44. 3Cer binding sites. Biochem. J. 368: 769-776.
45. Sandvig, K., S. Olnes, J. Brown, O. Peterson, and B. van Deurs. 1989. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108: 1331-1343.
46. Khine, A. A., and C. A. Lingwood. 1994. Capping and receptor mediated endocytosis of cell bound verotoxin(Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J. Cell. Physiol. 161: 319-332.
47. Schapiro, F., C. A. Lingwood, W. Furuya, and S. Grinstein. 1998. pH-independent targeting of glycolipids to the Golgi complex. Am. J. Physiol. 274: 319-332.
48. Nichols, B., A. Kenworthy, R. Polishchuk, R. Lodge, T. Roberts, K. Hirschberg, R. Phair, and J. Lippincott-Schwartz. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153: 529-541.
49. Khine, A. A., P. Tam, A. Nutikka, and C. A. Lingwood. 2004. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology. 14: 701-712.
50. Sandvig, K., E. Dubiniana, O. Garred, K. Prydz, J. V. Kozlov, S. H. Hansen, and B. van Deurs. 1992. Protein toxins: mode of action and cell entry. Biochem. Soc. Trans. 20: 724-727.
51. Johannes, L., D. Tenza, C. Anthony, and B. Goud. 1997. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 272: 19554-19561.
52. Saint-Pol, A., B. Yelamos, M. Amessou, I. G. Mills, M. Dugast, D. Tenza, P. Schu, C. Antony, H. T. McMahon, C. Lamaze, et al. 2004. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev. Cell. 6: 525-538.
53. Arab, S., M. Murakami, P. Dirks, B. Boyd, S. Hubbard, C. Lingwood, and J. Rutka. 1998. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J. Neurooncol. 40: 137-150.
54. Hoey, D. E. E., C. Currie, C. A. Lingwood, D. L. Gally, and D. G. E. Smith. 2003. Binding of verotoxin 1 to primary intestinal epithelial cells expressing Gb3 results in trafficking of toxin to lysosomal compartments. Cell. Microbiol. 5: 85-97.
55. Falguieres, T., W. Romer, M. Amessou, C. Afonso, C. Wolf, J. C. Tabet, C. Lamaze, and L. Johannes. 2006. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J. 273: 5205-5218.
56. Puri, A., P. Hug, K. Jernigan, J. Barchi, H-Y. Kim, J. Hamilton, J. Wiels, G. J. Murray, R. O. Brady, and R. Blumenthal. 1998. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 95: 14435-14440.
57. Fantini, J., D. Hammache, O. Delezay, N. Yahi, C. Andre-Barres, I. Rico-Lattes, and A. Lattes. 1997. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp 120 and inhibit HIV-1-induced fusion and entry. J. Biol. Chem. 272: 7245-7252.
58. Martensson, E. 1966. Neutral glycolipids of human kidney isolation, identification, and fatty acid composition. Biochim. Biophys. Acta. 116: 296-308.
59. Mizutani, Y., A. Kihara, and Y. Igarashi. 2005. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 390: 263-271.
60. Pewzner-Jung, Y., S. Ben-Dor, and A. H. Futerman. 2006. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J. Biol. Chem. 281: 25001-25005.
61. Wisniewska, A., J. Draus, and W. K. Subczynski. 2003. Is a fluid-mosaic model of biological membranes fully relevant? Studies on lipid organization in model and biological membranes. Cell. Mol. Biol. Lett. 8: 147-159.
62. Ångström, J., S. Tennenberg, M. Abul-Milh, I. Leonardsson, M. Ölwegård-Halvarsson, Å. Ljung, T. Wadström, and K-A. Karlsson. 1998. The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology. 8: 297-309.
63. de Almeida, R., A. Fedorov, and M. Prieto. 2003. Sphingomyelin/ phosphatidylcholine/cholesterol phase diagram: boundaries and composition of lipid rafts. Biophys. J. 85: 2406-2416.
64. Groves, J. T. 2007. Bending mechanics and molecular organization in biological membranes. Annu. Rev. Phys. Chem. 58: 697-717.
65. Brown, D., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14: 111-136.